Danimer Scientific, Inc.
Cash in trust
—
Not yet disclosed
Trust per share
—
Redemption value
IPO
May 2020
—
Combination deadline
—
Not disclosed
Filings on record
428
Latest May 15, 2025
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- Oct 5, 2020
- Closed
- Jan 5, 2021
Overview
Danimer Scientific, Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001779020. It completed its initial public offering in May 2020. Business combination closed; the company trades under a new ticker.
News on Danimer Scientific, Inc.
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001172661-25-002249
- 8-K
Other events
Items 1.03, 2.04, 8.01, 9.01 · Accession 0000950170-25-041367
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0000950170-25-030136
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001172661-25-001303
- 8-K
Entry into a material definitive agreement
Items 1.01, 2.04, 9.01 · Accession 0000950170-25-018029
- 4
Statement of changes in beneficial ownership
Accession 0000950170-25-017112
- 4
Statement of changes in beneficial ownership
Accession 0000950170-25-007293
- 25-NSE
Notification of delisting
Accession 0000876661-25-000043
- 4
Statement of changes in beneficial ownership
Accession 0000950170-25-001128
- 424B3
Prospectus supplement
Accession 0000950170-24-141341
- 8-K
Notice of delisting or failure to satisfy a listing rule; Regulation FD disclosure
Items 3.01, 7.01, 9.01 · Accession 0000950170-24-141335
- 424B3
Prospectus supplement
Accession 0000950170-24-137216
- 8-K
Entry into a material definitive agreement; Termination of a material definitive agreement; Regulation FD disclosure
Items 1.01, 1.02, 2.03, 2.04, 7.01, 9.01 · Accession 0000950170-24-137197
- 424B3
Prospectus supplement
Accession 0000950170-24-136283
- 8-K
Current report
Items 5.02, 9.01 · Accession 0000950170-24-136276
- 424B3
Prospectus supplement
Accession 0000950170-24-136052
- 8-K
Current report
Items 5.02, 9.01 · Accession 0000950170-24-135889
- 424B3
Prospectus supplement
Accession 0000950170-24-132815
- 8-K
Current report
Items 5.02, 9.01 · Accession 0000950170-24-132467
- 424B3
Prospectus supplement
Accession 0000950170-24-128604
- 10-Q
Quarterly report
Accession 0000950170-24-128298
- 8-K
Current report
Items 2.02, 9.01 · Accession 0000950170-24-128297
- NT 10-Q
Late quarterly report notification
Accession 0000950170-24-127672
- SC 13G
Beneficial ownership report (passive)
Accession 0001172661-24-005082
- 424B3
Prospectus supplement
Accession 0000950170-24-126240
- 8-K
Current report
Items 3.03, 5.03, 9.01 · Accession 0000950170-24-125968
- 424B3
Prospectus supplement
Accession 0000950170-24-116957
- 8-K
Submission of matters to a vote of security holders
Items 5.07, 9.01 · Accession 0000950170-24-116861
- 4
Statement of changes in beneficial ownership
Accession 0000950170-24-115962
- 424B3
Prospectus supplement
Accession 0000950170-24-115605
Pro
Track Danimer Scientific, Inc. without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
Danimer Scientific, Inc.: questions answered
What is Danimer Scientific, Inc.?
Danimer Scientific, Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001779020. It completed its initial public offering in May 2020. Business combination closed; the company trades under a new ticker.
How much does Danimer Scientific, Inc. hold in trust?
No trust balance has been disclosed in a filing we have indexed for Danimer Scientific, Inc.. For a newly priced IPO this is normal: the figure first appears in the quarterly report after closing.
When must Danimer Scientific, Inc. complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Danimer Scientific, Inc. does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Danimer Scientific, Inc., and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Danimer Scientific, Inc.?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
Is Danimer Scientific, Inc. a good investment?
That is not a question this site answers. Danimer Scientific, Inc. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Danimer Scientific, Inc. data come from?
Filings Danimer Scientific, Inc. submitted to the SEC under CIK 0001779020: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Sep 17, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
All completed de-spac transactions
Business combination closed; the company trades under a new ticker.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.